COMPANY
Atila Biosystems, Inc.
Timeline
- Trial start —: Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07232355 | Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling | Not listed | Recruiting | Aug 24, 2023 | 2026-06 (estimated) |
NIH awards 2
- NIH award 5R44CA272177-02 FY2023: $986,359 awarded for that fiscal year; activity R44 (SBIR); PI WANG, YOUXIANG; recipient as written: ATILA BIOSYSTEMS, INC., Sunnyvale, CA. PROGRESS: PRevention of cervical cancer us source ↗
- NIH award 1R44CA272177-01 FY2022: $1,011,310 awarded for that fiscal year; activity R44 (SBIR); PI WANG, YOUXIANG; recipient as written: ATILA BIOSYSTEMS, INC., Sunnyvale, CA. PROGRESS: PRevention of cervical cancer source ↗